Dealing with intellectual property in the life sciences sector is fraught with contention. There are many challenges associated with harnessing the power of natural phenomena and transforming it into something that is patent eligible.
In this webinar, Dr Lisa Haile explores issues and strategies for diagnostic and therapeutic patents and licenses, and will address some key questions.
- What strategies can be used to avoid the pitfalls associated with patenting around "laws of nature"?
- What are the effects of the Alice ruling and the Myriad Genetics case on patents?
Dr Lisa Haile
Lisa is a partner and co-chair of the Global Life Sciences Practice at DLA Piper. Her practice focuses on strategic counseling relating to all areas of biotechnology, pharma and life sciences intellectual property law.